Thoracic Vascular Stent Grafts Market Size & Share, by Type (Plastic, Metal); Product Type (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular); Application (Cardiac Aneurysm, Cardiovascular Diseases, Kidney Failure); End-user (Hospitals, Ambulatory Surgical Centers, Medical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 4304
Published Date: Feb 22, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Thoracic Vascular Stent Grafts Landscape

Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
JOTEC GmbH
Cook Group Incorporated
Terumo Corporation
Cardinal Health, Inc.
LeMaitre Vascular, Inc.
Merit Medical Systems, Inc.
Lombard Medical Ltd
Lifetech Scientific (Shenzhen) Co., Ltd.
Endologix LLC

Browse Key Market Insights with Data Illustration:

Thoracic Vascular Stent Grafts Market Analysis - Growth Outlook 2035

In the News

Terumo Corporation has launched the Thoraflex Hybrid Device for the treatment of complex aortic arch disease. The single-use device is comprised of a Gelweave polyester graft coupled to a Nitinol self-expanding stent.
Lifetech Scientific (Shenzhen) Co., Ltd. has attained a formal written notice from the National Medical Products Administration (“NMPA”) authorizing the admission of the Artery Stent Graft System (chimney technology) into the NMPA Special Examination and Approval Procedure for Innovative Medical Services. This is the world's first stent graft system engineered specifically for "chimney technology", a mainstream technology for treating aortic dissection lesions.

Frequently Asked Questions (FAQ)

Increasing geriatric population, growing cases of hypertension, increasing consumption of tobacco, and upsurge in fast food consumption are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

High cost of thoracic vascular stent grafts treatment, growing acceptance of balloon angioplasty, and associated hurdles with thoracic stent grafts are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic, JOTEC GmbH, Cook Group Incorporated, Terumo Corporation, Cardinal Health, Inc., LeMaitre Vascular, Inc., Merit Medical Systems, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, product type, application, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies Dominating the Thoracic Vascular Stent Grafts Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the thoracic vascular stent grafts market?

What would be the CAGR of thoracic vascular stent grafts market over the forecast period?

What are the challenges affecting the thoracic vascular stent grafts market growth?

Which region will provide more business opportunities for growth of thoracic vascular stent grafts market in future?

Who are the major players dominating the thoracic vascular stent grafts market?

How are the company profiles selected?

What are the segments in the thoracic vascular stent grafts market?

Which segment captures the largest market size in end-user segment in the thoracic vascular stent grafts market?